Brief: 9 Meters Biopharma Inc Announces Immuno-Oncology Collaboration With Gustave Roussy For NM-102
Nov 10 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* 9 METERS BIOPHARMA INC ANNOUNCES IMMUNO-ONCOLOGY
COLLABORATION
WITH GUSTAVE ROUSSY FOR NM-102, A GUT MICROBIOME MODULATOR
* 9 METERS BIOPHARMA INC - IND-ENABLING PATHWAY FOR NM-102
UNDERWAY WITH INDICATION SELECTION ANTICIPATED IN 2022
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection